Director-ICMR says no new mutant strain of Dengue in Delhi

Published On 2015-09-22 04:58 GMT   |   Update On 2015-09-22 04:58 GMT

Hinting at a positive control on an epidemic outbreak of dengue in Delhi, the recently appointed ICMR Director-General of ICMR is of the opinion that there is no new mutant strain of dengue in Delhi, hence the situation can be controlled if people are more cautious.Dr Soumya Swaminathan, a paediatrician and a researcher on infectious diseases, has also stated to PTI that four sero types...

Login or Register to read the full article
Hinting at a positive control on an epidemic outbreak of dengue in Delhi, the recently appointed ICMR Director-General of ICMR is of the opinion that there is no new mutant strain of dengue in Delhi, hence the situation can be controlled if people are more cautious.

Dr Soumya Swaminathan, a paediatrician and a researcher on infectious diseases, has also stated to PTI that four sero types circulate in India and this year, Delhi is seeing more of sero type 4 and 2. During his conversation, he clearly implies that the situation of dengue in Delhi is on the same pattern as every year. However, what differed is the sero types, and this year type 4 and 2 are most prominent. As reported by the MD team earlier, AIIMS has confirmed the sub-type virus of dengue few weeks back.

Commenting in the situation being further aggravated in the month of October, Dr Swaminathan has said that this year because we have not seen much rain in Delhi and there is no water stagnation, it is possible that it is already peaking and that we may see an actual decline in the cases in the next few weeks. If it rains again, and water starts collecting here and there, there are chances of a rise.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News